Dorzolamide Hydrochloride

CAS 130693-82-2 12 current records 4 historicalSmall Molecule

Who holds supplier records for Dorzolamide Hydrochloride? 12 organisations hold a current record for Dorzolamide Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), Spain (1), Italy (1), Netherlands (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Dorzolamide Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dorzolamide-hydrochloride

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    7 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Dorzolamide Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • CURIA SPAIN SAU
    Active DMF 18385 · latest filing May 2005
    SpainCEP Company GMP cert on record
  • FIS FABBRICA ITALIANA SINTETICI SPA
    Active DMF 20740, 29584 · latest filing Jul 2015
    ItalyCEP Company GMP cert on record
  • Hetero Drugs Limited
    Active DMF 26204, 21910 · latest filing Jul 2012
    IndiaCEP Company GMP cert on record
  • INDOCO REMEDIES LTD
    Active DMF 23795 · latest filing May 2010
    IndiaCEP Company GMP cert on record
  • MICRO LABS LTD
    Active DMF 24753 · latest filing Feb 2011
    IndiaCEP Company GMP cert on record
  • Neuland Laboratories Limited
    Active DMF 33024 · latest filing Nov 2018
    IndiaCEP
  • SHOBHA LIFE SCIENCES PRIVATE LIMITED
    Active DMF 41644 · latest filing Apr 2025
    IndiaCEP
  • TAPI NL BV
    Active DMF 20441 · latest filing Apr 2007
    NetherlandsCEP
  • C-SQUARED PHARMA LTD
    Active DMF 43885 · latest filing Apr 2026
    United States
  • CENTURY PHARMACEUTICALS LTD
    Active DMF 34797 · latest filing Jul 2020
  • FDC Limited
    Active DMF 20856, 33576 · latest filing Apr 2019
    IndiaCEP Company GMP cert on record
  • GLOBAL CALCIUM PRIVATE LTD
    Active DMF 39629 · latest filing Jul 2024
    India Company GMP cert on record
Need Dorzolamide Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (9)

Certificates of Suitability on the EDQM register for Dorzolamide Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 15 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
FDC LIMITED MumbaiIN
CEP 2023-236 - Rev 01
Dorzolamide hydrochloride, Process 2
Jul 2026—
SHOBHA LIFE SCIENCES PRIVATE LIMITED ChityalaIN
CEP 2025-065 - Rev 00
Dorzolamide hydrochloride
Aug 2025—
TAPI NL B.V. AmsterdamNL
CEP 2009-093 - Rev 04
Dorzolamide hydrochloride
Jul 2025—
CURIA SPAIN S.A.U. BoecilloES
CEP 2010-115 - Rev 04
Dorzolamide hydrochloride
Jul 2025Inspected Feb 2026
Spain
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2017-089 - Rev 01
Dorzolamide hydrochloride, Process II
May 2025—
MICRO LABS LIMITED BengaluruIN
CEP 2020-308 - Rev 02
Dorzolamide hydrochloride, Process-II
Oct 2024—
INDOCO REMEDIES LIMITED MumbaiIN
CEP 2011-015 - Rev 01
Dorzolamide hydrochloride
Dec 2023—
HETERO DRUGS LIMITED HyderabadIN
CEP 2017-050 - Rev 02
Dorzolamide hydrochloride
Nov 2023—
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
R1-CEP 2008-308 - Rev 03
Dorzolamide hydrochloride
Mar 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Dorzolamide Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • Bachem SA, Succursale de Vionnaz
    Switzerland · Inactive DMF 23385 · filed Dec 2009
  • Inactive DMF 21626 · filed May 2008
  • France · Inactive DMF 21349 · filed Feb 2008
  • India · Inactive DMF 20284 · filed Feb 2007

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Dorzolamide Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201162).

Chemical identity

IUPAC name
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
Canonical SMILES
CCN[C@H]1C[C@@H](S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl
InChIKey
OSRUSFPMRGDLAG-QMGYSKNISA-N
Synonyms
Cosopt pf, Dorzolamide (as hydrochloride), Dorzolamide hcl, Dorzolamide hydrochloride, Dorzolamide hydrochloride component of cosopt, MK-507, Trusopt, CHEBI:4703, Dorzolamide PF, Dorzolamide HCI, RefChem:57215, Dorzolamide Hydrochloride Ophthalmic

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Carbonic Anhydrase Inhibitor
Mechanism of action
Carbonic Anhydrase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Dorzolamide Hydrochloride?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Dorzolamide Hydrochloride: CURIA SPAIN SAU (Spain), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Hetero Drugs Limited (India), INDOCO REMEDIES LTD (India), MICRO LABS LTD (India), Neuland Laboratories Limited (India), SHOBHA LIFE SCIENCES PRIVATE LIMITED (India) and TAPI NL BV (Netherlands), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Dorzolamide Hydrochloride Drug Master Files are active?

CURIA SPAIN SAU (DMF 18385), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 20740, 29584), Hetero Drugs Limited (DMF 26204, 21910), INDOCO REMEDIES LTD (DMF 23795), MICRO LABS LTD (DMF 24753), Neuland Laboratories Limited (DMF 33024), SHOBHA LIFE SCIENCES PRIVATE LIMITED (DMF 41644) and TAPI NL BV (DMF 20441) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Dorzolamide Hydrochloride records mean?

4 organisations have only inactive Type II DMFs for Dorzolamide Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Dorzolamide Hydrochloride have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Dorzolamide Hydrochloride on the EDQM register, including FDC LIMITED Mumbai (IN), SHOBHA LIFE SCIENCES PRIVATE LIMITED Chityala (IN), TAPI NL B.V. Amsterdam (NL), CURIA SPAIN S.A.U. Boecillo (ES), NEULAND LABORATORIES LIMITED Hyderabad (IN) and MICRO LABS LIMITED Bengaluru (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Dorzolamide Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Dorzolamide Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.